Atlas Trials

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

Clinical trial NCT01986062 · COMPLETED

Trial details

NCT number
NCT01986062
Sponsor
Arbor Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder (ADHD)
Start date
2013-12-01
Primary completion
2014-05-01
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.